WILEY MATTHEW T. (Chief Commercial Officer) sold 0.9% of their position (3.10K shares) of DEFINIUM THERAPEUTICS, INC. on the open market
Open‑market sale worth $113.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/30/2026ACC: 0001104659-26-112061
Officer· Chief Commercial Officer
Since Feb 2026
-3.10K
Net shares
Net seller
$113.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.10K disposed
Non-Derivative Transactions1
Common Shares
Direct
Shares
−3.10K
Price / share
$36.57
Trade value
$113.26K
% of position
0.9%
9/25/2026
362.13K→359.04K
Total
Net shares
−3.10K
Net value
-$113.26K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 9/25/2026 | S · Sale | −3.10K | $36.57 | $113.26K | 0.9% | 362.13K | 359.04K |
| Total | −3.10K | -$113.26K | ||||||
Derivative Transactions0
No derivative transactions reported